3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
6
Pancreatic Neoplasms
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Lymphoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
10
Paclitaxel
8
Taxes
6
Nivolumab
4
Cyclophosphamide
4
Cisplatin
4
Carboplatin
4
Polymerase Chain Reaction
3
Irinotecan
3
Interleukin-12 Subunit p35
3
Docetaxel
3
Bevacizumab
3
sargramostim
2
lenvatinib
2
aldesleukin
2
aflibercept
2
Trastuzumab
2
SS1(dsFv)PE38
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Methods
2
Interleukin-12
2
Gene Expression Profiling
2
Gemcitabine
2
Filgrastim
2
Early Intervention, Educational
2
Capecitabine
2
Albumin-Bound Paclitaxel
2
veliparib
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Referral and Consultation
×
Gastrointestinal
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled